Convection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatment

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 2, 2014, Pages 381-391

  Xi, Guifa ^a   Robinson, Erik ^b,d,e,f,g   Mania Farnell, Barbara ^c   Vanin, Elio Fausto ^a   Shim, Kyu Won ^a   Takao, Tsurubuchi ^a   Allender, Elise Victoria ^a   Mayanil, Chandra Shekhar ^a   Soares, Marcelo Bento ^a   Ho, Dean ^b,d,e,f,g   Tomita, Tadanori ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c PURDUE UNIVERSITY CALUMET   (United States)

^d UCLA SCHOOL OF DENTISTRY   (United States)

^e Department of Bioengineering ^*  (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Convection enhanced delivery (CED); Doxorubicin (Dox); Glioma; Nanodiamonds (NDs)

Indexed keywords

BRAIN TUMOR TREATMENTS; CONVECTION-ENHANCED DELIVERY; DOXORUBICIN; DRUG DELIVERY SYSTEM; DRUG RETENTION; GLIOMA; GLIOMA CELL LINES; INTRACRANIAL TUMORS;

CELL CULTURE; DRUG DELIVERY; TOXICITY; TUMORS;

NANODIAMONDS;

DOXORUBICIN; NANODIAMOND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BRAIN TISSUE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CONVECTION ENHANCED DELIVERY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG RETENTION; DRUG UPTAKE; GLIOMA; GLIOMA CELL; IN VITRO STUDY; MALE; NONHUMAN; RAT; TUMOR CELL LINE;

CONVECTION-ENHANCED DELIVERY (CED); DOXORUBICIN (DOX); GLIOMA; NANODIAMONDS (NDS);

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG CARRIERS; GLIOMA; HUMANS; MALE; NANODIAMONDS; NANOMEDICINE; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED F344; TISSUE DISTRIBUTION;

EID: 84893342240     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.07.013     Document Type: Article

References (47)

1. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352(10):987-996.
2. Stupp R., Hegi M.E., Mason W.P., van den Bent M.J., Taphoorn M.J., Janzer R.C., et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009, 10(5):459-466.
3. Lefranc F., Brotchi J., Kiss R. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 2005, 23(10):2411-2422.
4. Messinger Y.H., Gaynon P.S., Sposto R., van der Giessen J., Eckroth E., Malvar J., et al. Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study. Blood 2012, 120(2):285-290.
5. Opel D., Poremba C., Simon T., Debatin K.M., Fulda S. Activation of Akt predicts poor outcome in neuroblastoma. Cancer Res 2007, 67(2):735-745.
6. Blick C., Hall P., Pwint T., Al-Terkait F., Crew J., Powles T., et al. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder. Cancer 2012, 118(16):3920-3927.
7. Ismael G., Hegg R., Muehlbauer S., Heinzmann D., Lum B., Kim S.B., et al. Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial. Lancet Oncol 2012, 13(9):869-878.
8. Yang F.Y., Wang H.E., Liu R.S., Teng M.C., Li J.J., Lu M., et al. Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound. PLoS One 2012, 7(9):e45468.
9. Liu S., Guo Y., Huang R., Li J., Huang S., Kuang Y., et al. Gene and doxorubicin co-delivery system for targeting therapy of glioma. Biomaterials 2012, 33(19):4907-4916.
10. Kroll R.A., Neuwelt E.A. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 1998, 42(5):1083-1099. discussion 99-100.
11. Matsukado K., Inamura T., Nakano S., Fukui M., Bartus R.T., Black K.L. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery 1996, 39(1):125-133. discussion 33-4.
12. Nakamura T., Saito R., Sugiyama S., Sonoda Y., Kumabe T., Tominaga T. Local convection-enhanced delivery of chemotherapeutic agent transiently opens blood-brain barrier and improves efficacy of systemic chemotherapy in intracranial xenograft tumor model. Cancer Lett 2011, 310(1):77-83.
13. Groothuis D.R. The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro Oncol 2000, 2(1):45-59.
14. Walter K.A., Tamargo R.J., Olivi A., Burger P.C., Brem H. Intratumoral chemotherapy. Neurosurgery 1995, 37(6):1128-1145.
15. Xi G., Rajaram V., Mania-Farnell B., Mayanil C.S., Soares M.B., Tomita T., et al. Efficacy of vincristine administered via convection-enhanced delivery in a rodent brainstem tumor model documented by bioluminescence imaging. Childs Nerv Syst 2012, 28(4):565-574.
16. Xi G., Mania-Farnell B., Rajaram V., Mayanil C.S., Soares M.B., Tomita T., et al. Efficacy of interstitial continuous vincristine infusion in a bioluminescent rodent intracranial tumor model. J Neurooncol 2012, 106(2):261-270.
17. Kawabata S., Yang W., Barth R.F., Wu G., Huo T., Binns P.J., et al. Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors. J Neurooncol 2011, 103(2):175-185.
18. Kikuchi T., Saito R., Sugiyama S., Yamashita Y., Kumabe T., Krauze M., et al. Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models. J Neurosurg 2008, 109(5):867-873.
19. Mardor Y., Rahav O., Zauberman Y., Lidar Z., Ocherashvilli A., Daniels D., et al. Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring. Cancer Res 2005, 65(15):6858-6863.
20. Song D.K., Lonser R.R. Convection-enhanced delivery for the treatment of pediatric neurologic disorders. J Child Neurol 2008, 23(10):1231-1237.
21. Degen J.W., Walbridge S., Vortmeyer A.O., Oldfield E.H., Lonser R.R. Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. J Neurosurg 2003, 99(5):893-898.
22. Bobo R.H., Laske D.W., Akbasak A., Morrison P.F., Dedrick R.L., Oldfield E.H. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 1994, 91(6):2076-2080.
23. Shimkunas R.A., Robinson E., Lam R., Lu S., Xu X., Zhang X.Q., et al. Nanodiamond-insulin complexes as pH-dependent protein delivery vehicles. Biomaterials 2009, 30(29):5720-5728.
24. Liu K.K., Zheng W.W., Wang C.C., Chiu Y.C., Cheng C.L., Lo Y.S., et al. Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy. Nanotechnology 2010, 21(31):315106.
25. Mochalin V.N., Shenderova O., Ho D., Gogotsi Y. The properties and applications of nanodiamonds. Nat Nanotechnol 2012, 7(1):11-23.
26. Liang Y., Ozawa M., Krueger A. A general procedure to functionalize agglomerating nanoparticles demonstrated on nanodiamond. ACS Nano 2009, 3(8):2288-2296.
27. Barnard A.S. Self-assembly in nanodiamond agglutinates. Journal of Materials Chemistry 2008, 18(34):4038.
28. Lai L., Barnard A.S. Interparticle interactions and self-assembly of functionalized nanodiamonds. J Phys Chem Lett 2012, 3(7):896-901.
29. Kim H., Man H.B., Saha B., Kopacz A.M., Lee O.S., Schatz G.C., et al. Multiscale simulation as a framework for the enhanced design of nanodiamond-polyethylenimine-based gene delivery. J Phys Chem Lett 2012, 3(24):3791-3797.
30. Schmidlin L., Pichot V., Comet M., Josset S., Rabu P., Spitzer D. Identification, quantification and modification of detonation nanodiamond functional groups. Diamond and Related Materials. 2012, 22:113-117.
31. Huang H., Pierstorff E., Osawa E., Ho D. Protein-mediated assembly of nanodiamond hydrogels into a biocompatible and biofunctional multilayer nanofilm. ACS Nano 2008, 2(2):203-212.
32. Liu K.K., Chang C.C., Chao J.I. Biocompatible and detectable carboxylated nanodiamond on human cell. Nanotechnology. 2007, 18:325102.
33. Zhang X., Yin J., Kang C., Li J., Zhu Y., Li W., et al. Biodistribution and toxicity of nanodiamonds in mice after intratracheal instillation. Toxicol Lett 2010, 198(2):237-243.
34. Bianco A., Kostarelos K., Prato M. Opportunities and challenges of carbon-based nanomaterials for cancer therapy. Expert Opin Drug Deliv 2008, 5(3):331-342.
35. Chow E.K., Zhang X.Q., Chen M., Lam R., Robinson E., Huang H., et al. Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment. Sci Transl Med 2011, 3(73):73ra21.
36. Hynynen K., Pomeroy O., Smith D.N., Huber P.E., McDannold N.J., Kettenbach J., et al. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology 2001, 219(1):176-185.
37. Yamashita Y., Saito R., Krauze M.T., Kawaguchi T., Noble C., Drummond D.C., et al. Convection-enhanced delivery of liposomal doxorubicin in intracranial brain tumor xenografts. Targeted Oncology 2006, 1(2):79-85.
38. Aoki Y., Hashizume R., Ozawa T., Banerjee A., Prados M., James C.D., et al. An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing. J Neurooncol 2012, 108(1):29-35.
39. Iwami K., Momota H., Natsume A., Kinjo S., Nagatani T., Wakabayashi T. A novel method of intracranial injection via the postglenoid foramen for brain tumor mouse models. J Neurosurg 2012, 116(3):630-635.
40. Prasad G., Sottero T., Yang X., Mueller S., James C.D., Weiss W.A., et al. Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide. Neuro Oncol 2011, 13(4):384-392.
41. Wong H.L., Bendayan R., Rauth A.M., Xue H.Y., Babakhanian K., Wu X.Y. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. J Pharmacol Exp Ther 2006, 317(3):1372-1381.
42. Li J., Zhu Y., Li W., Zhang X., Peng Y., Huang Q. Nanodiamonds as intracellular transporters of chemotherapeutic drug. Biomaterials 2010, 31(32):8410-8418.
43. Faklaris O., Garrot D., Joshi V., Druon F., Boudou J.P., Sauvage T., et al. Detection of single photoluminescent diamond nanoparticles in cells and study of the internalization pathway. Small 2008, 4(12):2236-2239.
44. Kunwar S., Chang S., Westphal M., Vogelbaum M., Sampson J., Barnett G., et al. Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol 2010, 12(8):871-881.
45. Bidros D.S., Liu J.K., Vogelbaum M.A. Future of convection-enhanced delivery in the treatment of brain tumors. Future Oncol 2010, 6(1):117-125.
46. Saito R., Krauze M.T., Bringas J.R., Noble C., McKnight T.R., Jackson P., et al. Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Exp Neurol 2005, 196(2):381-389.
47. Manus L.M., Mastarone D.J., Waters E.A., Zhang X.Q., Schultz-Sikma E.A., Macrenaris K.W., et al. Gd(III)-nanodiamond conjugates for MRI contrast enhancement. Nano Lett 2010, 10(2):484-489.